Funds and ETFs Changzhou Qianhong Biopharma CO.,LTD

Equities

002550

CNE100001070

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-05-23 pm EDT 5-day change 1st Jan Change
5.8 CNY +0.87% Intraday chart for Changzhou Qianhong Biopharma CO.,LTD 0.00% -1.36%

ETFs positioned on Changzhou Qianhong Biopharma CO.,LTD

Name Weight AuM 1st Jan change Investor Rating
0.00% 34 M€ +4.20% -
Changzhou Qianhong Biopharma CO., LTD is a China-based company, principally engaged in the research and development, production and distribution of freeze-drying powder, freeze-drying powder injections, small volume injections, tablets, hard capsules, granules and bulk drugs, among others. The Company mainly provides liquaemin sodium raw materials and preparations, applied to prevent and treat thromboembolism desease; kallidinogen preparations, applied in the treatment of micro-circulation disorder disease, asparaginase bulk drugs and preparations, applied in the treatment of acute lymphoblastic leukemia, as well as compound digestive enzyme capsules II. The Company distributes its products within domestic market and to overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
5.8 CNY
Average target price
6.12 CNY
Spread / Average Target
+5.52%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 002550 Stock
  4. Funds and ETFs Changzhou Qianhong Biopharma CO.,LTD